Concepedia

Nickolas Attanasio

NA

Statistics

Publications

3

Citations

119

H-Index

3

Active since

2019

Affiliations

Oxford Biotherapeutics (United Kingdom)(Current)

Menarini Group (Italy)

Nickolas Attanasio is an author at Oxford Biotherapeutics (United Kingdom) specializing in oncology, pharmacology, and cancer pharmacology.

Publications per year

2019–2021

3

Publications

3

Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study

Marc Oliva, Douglas B. Chepeha, Daniel Vilarim Araújo et al. · Journal for ImmunoTherapy of Cancer · 2021 · 52 citations · Full text

, , +17

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models

Eugenio Gaudio, Chiara Tarantelli, Filippo Spriano et al. · Haematologica · 2020 · 39 citations · Full text

, , +17

MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni et al. · Molecular Cancer Therapeutics · 2019 · 28 citations · Full text

, , +17

1–3 of 3